Phenyl-γ-valerolactone has neuroprotective properties and inhibits neurotoxic protein aggregate deposition, such as amyloid and tau in brain tissues [337], and promotes memory retention, preventing cognitive decline in an AD mouse model [338]. This evidence concerns the gene MAPT and Alzheimer disease.